We are live on ! Find out more
BHC icon

Bausch Health

324 hedge funds and large institutions have $3.58B invested in Bausch Health in 2020 Q3 according to their latest regulatory filings, with 60 funds opening new positions, 101 increasing their positions, 102 reducing their positions, and 37 closing their positions.

New
Increased
Maintained
Reduced
Closed

62% more first-time investments, than exits

New positions opened: 60 | Existing positions closed: 37

32% more call options, than puts

Call options by funds: $180M | Put options by funds: $136M

7% more funds holding

Funds holding: 303324 (+21)

1% less repeat investments, than reductions

Existing positions increased: 101 | Existing positions reduced: 102

1.64% less ownership

Funds ownership: 65.99%64.35% (-1.6%)

14% less funds holding in top 10

Funds holding in top 10: 1412 (-2)

17% less capital invested

Capital invested by funds: $4.29B → $3.58B (-$708M)

Holders
324
Holders Change
+21
Holders Change %
+6.93%
% of All Funds
6.54%
Holding in Top 10
12
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-14.29%
% of All Funds
0.24%
New
60
Increased
101
Reduced
102
Closed
37
Calls
$180M
Puts
$136M
Net Calls
+$43.8M
Net Calls Change
+$20M
Name Holding Trade Value Shares
Change
Change in
Stake
PAMU
126
Pictet Asset Management (UK)
United Kingdom
$1.81M -$131K -7,600 -6%
XSC
127
X-Square Capital
Puerto Rico
$1.8M -$321K -18,637 -14%
RJA
128
Raymond James & Associates
Florida
$1.77M -$391K -22,689 -17%
RHAM
129
Round Hill Asset Management
California
$1.74M -$3.51K -204 -0.2%
FSA
130
Financial Sense Advisors
California
$1.73M -$3.44K -200 -0.2%
AI
131
Atom Investors
Texas
$1.66M +$1.84M +106,751 New
GFA
132
Gifford Fong Associates
California
$1.55M
CA
133
Continental Advisors
Utah
$1.55M +$499K +29,000 +41%
Grantham, Mayo, Van Otterloo & Co (GMO)
134
Grantham, Mayo, Van Otterloo & Co (GMO)
Massachusetts
$1.54M -$2.08M -120,900 -55%
Franklin Resources
135
Franklin Resources
California
$1.52M -$25.1K -1,458 -1%
Arrowstreet Capital
136
Arrowstreet Capital
Massachusetts
$1.5M +$1.67M +96,800 New
D.E. Shaw & Co
137
D.E. Shaw & Co
New York
$1.49M +$443K +25,728 +37%
OGC
138
One68 Global Capital
New York
$1.46M +$1.62M +93,831 New
Mitsubishi UFJ Trust & Banking
139
Mitsubishi UFJ Trust & Banking
Japan
$1.45M +$38.4K +2,231 +2%
BCI
140
Brinker Capital Investments
Pennsylvania
$1.35M +$1.49M +86,584 New
Neuberger Berman Group
141
Neuberger Berman Group
New York
$1.34M -$543K -31,522 -27%
SC
142
Scotia Capital
Ontario, Canada
$1.33M +$1.47M +85,521 New
Nomura Holdings
143
Nomura Holdings
Japan
$1.24M +$1.17M +68,000 +567%
Baird Financial Group
144
Baird Financial Group
Wisconsin
$1.22M -$181K -10,500 -12%
CRC
145
Curi RMB Capital
Illinois
$1.21M +$615K +35,686 +84%
Wolverine Trading
146
Wolverine Trading
Illinois
$1.18M +$1.36M +79,157 New
PCMK
147
Paragon Capital Management (Kansas)
Kansas
$1.17M -$3.75K -218 -0.3%
HHAA
148
Henry H. Armstrong Associates
Pennsylvania
$1.15M
AAMU
149
Amundi Asset Management US
Massachusetts
$1.11M -$50.7K -2,944 -4%
Envestnet Asset Management
150
Envestnet Asset Management
Illinois
$1.08M +$268K +15,565 +29%

BHC Hedge Fund Activity: Q3 2020 in Review

324 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Bausch Health (BHC) for Q3 2020, worth a combined $3.58B — down 17% from $4.29B a quarter earlier.

Buyers outnumbered sellers: 60 funds opened new BHC positions and 37 closed out — a net gain of 23 holders — while 101 added to existing stakes and 102 trimmed.

The largest buyer was Camber Capital Management, opening a new position worth an estimated $77.5M. The largest seller was Fidelity International, cutting an estimated $295M.

  • 324 institutional investors held Bausch Health (BHC) as of Q3 2020, up from 303 in Q2 2020.
  • Funds reported $3.58B of Bausch Health stock for Q3 2020, down 17% quarter-over-quarter.
  • 60 funds opened new Bausch Health positions in Q3 2020 and 37 closed out, a net change of +23 holders.
  • The largest Bausch Health buyer in Q3 2020 was Camber Capital Management, an estimated $77.5M added.
  • The largest Bausch Health seller in Q3 2020 was Fidelity International, an estimated $295M sold.

Based on aggregated 13F filings for Q3 2020.